1. Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis
- Author
-
Leodori, Giorgia, Pellicano, Chiara, Basile, Valerio, Colalillo, Amalia, Navarini, Luca, Gigante, Antonietta, Gulli, Francesca, Marino, Mariapaola, Basile, Umberto, Rosato, Edoardo, Marino, Mariapaola (ORCID:0000-0001-9155-6378), Leodori, Giorgia, Pellicano, Chiara, Basile, Valerio, Colalillo, Amalia, Navarini, Luca, Gigante, Antonietta, Gulli, Francesca, Marino, Mariapaola, Basile, Umberto, Rosato, Edoardo, and Marino, Mariapaola (ORCID:0000-0001-9155-6378)
- Abstract
The aim was to evaluate the longitudinal association between basal serum adiponectin and repeated measurements of skin thickness during 12 months of follow-up in systemic sclerosis (SSc) patients. We enrolled SSc patients with disease duration > 2 years in a prospective observational study. Skin thickness was measured at baseline and after 12 months of follow-up with modified Rodnan skin score (mRSS). Baseline serum adiponectin was determined using a commercial ELISA kit. We enrolled 66 female SSc patients (median age 54 years, IQR 42-62 years). The median disease duration was 12 (IQR 8-16) years and median baseline serum adiponectin was 9.8 (IQR 5.6-15.6) mcg/mL. The median mRSS was 10 (IQR 6-18) at baseline and 12 (IQR 7-18) at follow-up. A significant correlation was observed between baseline serum adiponectin and disease duration (r = 0.264, p < 0.05), age (r = 0.515, p < 0.0001), baseline mRSS (r = -0.303, p < 0.05), and mRSS at follow-up (r = -0.322, p < 0.001). In multiple regression analysis, only mRSS at follow-up showed an inverse correlation with baseline serum adiponectin (beta = -0.132, p < 0.01). The reduction in serum adiponectin levels is correlated with skin thickness.
- Published
- 2022